Edition:
United States

CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

16.76USD
18 Jan 2019
Change (% chg)

$0.05 (+0.30%)
Prev Close
$16.71
Open
$16.77
Day's High
$17.04
Day's Low
$16.50
Volume
76,424
Avg. Vol
153,774
52-wk High
$34.98
52-wk Low
$12.56

Chart for

About

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeutics against difficult-to-drug targets. Its pipeline is focused on the development... (more)

Overall

Beta: --
Market Cap(Mil.): $611.20
Shares Outstanding(Mil.): 45.01
Dividend: --
Yield (%): --

Financials

  CTMX.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -1.93 -- --
ROI: -21.75 0.60 13.80
ROE: -76.25 -2.18 15.29

Earnings vs. Estimates